loadpatents
Patent applications and USPTO patent grants for TenHoor; Christopher.The latest application filed is for "assays for determining plasma kallikrein system biomarkers".
Patent | Date |
---|---|
Assays For Determining Plasma Kallikrein System Biomarkers App 20220291232 - Sexton; Daniel J. ;   et al. | 2022-09-15 |
Assays for determining plasma kallikrein system biomarkers Grant 11,372,002 - Sexton , et al. June 28, 2 | 2022-06-28 |
Evaluation And Treatment Of Bradykinin-mediated Disorders App 20220170936 - Sexton; Daniel J. ;   et al. | 2022-06-02 |
Methods of determining levels of cleaved and/or intact kininogen Grant 11,156,612 - Sexton , et al. October 26, 2 | 2021-10-26 |
Fc Receptor Binding Proteins App 20210309741 - Sexton; Daniel J. ;   et al. | 2021-10-07 |
Plasma kallikrein binding proteins and uses thereof in treating hereditary angioedema Grant 11,084,884 - Sexton , et al. August 10, 2 | 2021-08-10 |
Nucleic acids encoding anti-neonatal Fc receptor (FcRn) antibodies Grant 11,014,988 - Sexton , et al. May 25, 2 | 2021-05-25 |
Plasma Kallikrein Binding Proteins And Uses Thereof In Treating Hereditary Angioedema App 20210087293 - Sexton; Daniel J. ;   et al. | 2021-03-25 |
Fc Receptor Binding Proteins App 20200109199 - Sexton; Daniel J. ;   et al. | 2020-04-09 |
Fc receptor antibodies and methods of use thereof Grant 10,479,834 - Sexton , et al. Nov | 2019-11-19 |
Fc Receptor Binding Proteins App 20180305454 - Sexton; Daniel J. ;   et al. | 2018-10-25 |
Methods of producing antibodies to neonatal Fc receptor (FcRn) Grant 9,862,768 - Sexton , et al. January 9, 2 | 2018-01-09 |
Plasma Kallikrein Binding Proteins And Uses Thereof In Treating Hereditary Angioedema App 20170002094 - Sexton; Daniel J. ;   et al. | 2017-01-05 |
Fc Receptor Binding Proteins App 20160304608 - SEXTON; Daniel J. ;   et al. | 2016-10-20 |
Assays For Determining Plasma Kallikrein System Biomarkers App 20160252527 - Sexton; Daniel J. ;   et al. | 2016-09-01 |
Fc Receptor Binding Proteins App 20160222108 - TenHoor; Christopher ;   et al. | 2016-08-04 |
Fc Receptor Binding Proteins App 20160222109 - TenHoor; Christopher ;   et al. | 2016-08-04 |
Fc Receptor Binding Proteins App 20160222112 - TenHoor; Christopher ;   et al. | 2016-08-04 |
Fc Receptor Binding Proteins App 20160222111 - TenHoor; Christopher ;   et al. | 2016-08-04 |
Fc Receptor Binding Proteins App 20160222110 - TenHoor; Christopher ;   et al. | 2016-08-04 |
Fc Receptor Binding Proteins App 20160194397 - TenHoor; Christopher ;   et al. | 2016-07-07 |
Human neonatal Fc receptor antibodies and methods of use thereof Grant 9,359,438 - Sexton , et al. June 7, 2 | 2016-06-07 |
Antibodies to FeRn and uses thereof Grant 9,260,520 - TenHoor , et al. February 16, 2 | 2016-02-16 |
Evaluation And Treatment Of Bradykinin-mediated Disorders App 20150362493 - Sexton; Daniel J. ;   et al. | 2015-12-17 |
Fc Receptor Binding Proteins App 20140308206 - Sexton; Daniel J. ;   et al. | 2014-10-16 |
Fc Receptor Binding Proteins App 20140248287 - TenHoor; Christopher ;   et al. | 2014-09-04 |
Fc receptor binding proteins Grant 8,815,246 - TenHoor , et al. August 26, 2 | 2014-08-26 |
Fc Receptor Binding Proteins App 20130078262 - TenHoor; Christopher ;   et al. | 2013-03-28 |
Fc Receptor Binding Proteins App 20130045218 - TenHoor; Christopher ;   et al. | 2013-02-21 |
Fc receptor binding proteins Grant 8,273,351 - TenHoor , et al. September 25, 2 | 2012-09-25 |
Fc Receptor Binding Proteins App 20090324614 - TenHoor; Christopher ;   et al. | 2009-12-31 |
Methods and Compositions Comprising Anti-Idiotypic Antibodies to Anti-MMP-14 Antibodies App 20090275124 - Muruganandam; Arumugam ;   et al. | 2009-11-05 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.